The FTC orders gene-sequencing company Illumina to divest cancer-test developer Grail. The hospital industry pushes back against likely nursing home staff mandates in an upcoming CMS proposed rule. And, Mark Cuban’s prescription drug company will sell brand-name diabetes drugs for the first time. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
